UBS ETFPour continuer, merci de confirmer que vous résidez en Suisse.
UBS ETF (IE) MSCI World Select Factor Mix UCITS ETF
Dernière mise à jour
Asset Class: Equities
Securities lending is the temporary transfer of securities from the lender (the fund management company) in the name of and for the account of the investment fund to a third party (the borrower). In exchange, the borrower provides the lender with collateral before the delivery of securities, and pays a fee over the period of the loan. All loans within our lending programme are open and rolled daily such that they can be extended or terminated on demand. The fund can thus generate additional income. UBS ETFs engage in securities lending for selected, physically replicated UBS ETFs with the aim of reducing the investor’s net costs. Securities lending with UBS ETFs is always over-collateralised with at least 105% margin across all asset classes. In addition, on-loan balances are capped at 50% of each sub-fund’s AUM. Collateral is held in a custody account that is kept separate from the intermediary’s balance sheet. Daily revaluation at market prices ensures that the value of the collateral provided is always adjusted correctly. To further minimise risks, borrowers are carefully selected. The following types of securities are accepted as collateral (excl. securities of the borrowing counterparty):
- Securities issued and/or guaranteed by the governments of the following countries:
- The following G10 countries: Belgium, the Netherlands, Canada, Sweden, France, Switzerland (SNB Bills), Germany, Japan, UK and USA (including US debt securities and rights issued or guaranteed by the US administration or one of its agencies or instrumentalities.)
- Only the following OECD countries: Australia, Austria, Denmark, Finland, Luxembourg, New Zealand and Norway.
- Equities in the form of world stock indices.
Collateralisation of the securities lending is continually reviewed and adjusted as necessary. It can therefore be subject to change. For more details about Securities Lending Borrowers please follow the link.
Collateral 12 month lending summary (as of last month end)
Min % balance on loan:
Max % balance on loan:1)
Average % balance on loan:2)
Net return to fund in bps:3)
Source: State Street
1) The maximum loan value is calculated from the maximum value of the lent securities on a single day within the past 12 months.
2) The average loan value is calculated by dividing the average percentage value of the securities lent on a daily basis by the fund's daily assets under management (AuM) over the past 12 months.
3) The fund's annualised net return generated by securities lending is calculated by dividing the fund's securities lending income over a period of 12 months by the fund's average net asset value (NAV) for the same period.
Of the revenue received by the borrower on the market, 60% is credited to the relevant sub-fund while UBS AG receives 20% to cover the due diligence and the Securities Lending Agent 20% to cover operational costs resulting from the transactions carried out in relation to the securities lending.
Top 10 collateral holdings
GERMANY, REPUBLIC OF 4.25000% 07-04.07.39
AMERICA, UNITED STATES OF 0.125%/CPI LINKED 19-15.10.24
AMERICA, UNITED STATES OF 2.25000% 16-15.08.46
02FSWFRENCH REPUBLIC GOVER
FRANCE, REPUBLIC OF-OAT 2.50000% 13-25.05.30
UNITED KINGDOM OF GREAT BRITAIN & N IRL 3.25000% 12-22.01.44
FRANCE, REPUBLIC OF-OAT-REG-S 0.00000% 16-25.05.21
CANADA, GOVERNMENT 2.75000% 14-01.12.48
UNITED KINGDOM OF GREAT BRITAIN & N IRL 3.50000% 14-22.01.45
CANADA, GOVERNMENT 0.75000% 16-01.09.21
The table above lists the securities that are used as collateral for the securities lent with UBS ETFs. The information presented was obtained from internal and external sources deemed reliable. However, we cannot provide any guarantee of their accuracy and completeness. It should be noted that securities lending is subject to a certain risk where the borrower does not return the borrowed securities according to his/her obligation, and where the value of the collateral provided does not cover the costs of repurchase of the securities. In this case, the borrower shall be liable for any claims arising from the securities lending and not covered by the sale of the securities concerned. Source: State Street, 20.11.2019
For marketing and information purposes by UBS. Representative in Italy for UBS funds, UBS Asset Management (Italia) SGR S.p.A., Via del Vechio Politecnico, n.3, 20121 Milano (MI), Italy. The prospectus, the simplified prospectus or Key investor information, the fund regulations, as well as the Articles of Association for UBS SICAVs and the latest annual or semi-annual report may be obtained free of charge from UBS Asset Management (Italia) SGR S.p.A., Via del Vechio Politecnico, n.3, 20121 Milano (MI), Italy. The MSCI indexes are the exclusive property of MSCI INC. (“MSCI”). MSCI and the MSCI index names are service mark(s) of MSCI or its affiliates and have been licensed for use for certain purposes by UBS AG (“UBS”). The financial securities referred to herein are not sponsored, endorsed, or promoted by MSCI, and MSCI bears no liability with respect to any such financial securities. The full prospectus of the UBS ETF Sicav contains a more detailed description of the limited relationship MSCI has with UBS and any related financial securities. No purchaser, seller or holder of this product, or any other person or entity, should use or refer to any MSCI trade name, trademark or service mark to sponsor, endorse, market or promote this product without first contacting MSCI to determine whether MSCI’s permission is required. Under no circumstances may any person or entity claim any affiliation with MSCI without the prior written permission of MSCI. Before investing in a product please read the latest prospectus carefully and thoroughly. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. Members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS Asset Management Switzerland AG or a local affiliated company. Source for all data and charts (if not indicated otherwise): UBS Asset Management. More explanations of financial terms can be found at ubs.com/glossary © UBS 2019. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.